These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10188640)

  • 1. Decreased hippocampal (CA3) NMDA receptors in schizophrenia.
    Dean B; Scarr E; Bradbury R; Copolov D
    Synapse; 1999 Apr; 32(1):67-9. PubMed ID: 10188640
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of NMDA-coupled and dopamine reuptake carrier coupled [3H]-TCP binding sites in guinea pig brain.
    Reid AA; Monn JA; Jacobson AE; Rice KC; Rothman RB
    NIDA Res Monogr; 1989; 95():530-1. PubMed ID: 2561850
    [No Abstract]   [Full Text] [Related]  

  • 3. SNAP-25 reduction in the hippocampus of patients with schizophrenia.
    Thompson PM; Egbufoama S; Vawter MP
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):411-7. PubMed ID: 12691775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of dopamine-D2 receptors on lymphocytes using the binding technic].
    Della Bella S; Fonticoli L; Pizzi N
    Medicina (Firenze); 1988; 8(1):73-5. PubMed ID: 2976109
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.
    Mueller HT; Haroutunian V; Davis KL; Meador-Woodruff JH
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):60-9. PubMed ID: 14969737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
    Callier S; Morissette M; Grandbois M; Pélaprat D; Di Paolo T
    Synapse; 2001 Aug; 41(2):131-8. PubMed ID: 11400179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lack of association between VNTR polymorphism of DAT gene and schizophrenia].
    Hauser J; Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Twardowska K; Rybakowski JK
    Psychiatr Pol; 2002; 36(3):403-12. PubMed ID: 12149916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond monoamine-based therapies: clues to new approaches.
    Skolnick P
    J Clin Psychiatry; 2002; 63 Suppl 2():19-23. PubMed ID: 15453010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.
    Sawada K; Barr AM; Nakamura M; Arima K; Young CE; Dwork AJ; Falkai P; Phillips AG; Honer WG
    Arch Gen Psychiatry; 2005 Mar; 62(3):263-72. PubMed ID: 15753239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal dystonia is associated with a polymorphism of the dopamine D5 receptor gene.
    Misbahuddin A; Placzek MR; Warner TT
    Adv Neurol; 2004; 94():143-6. PubMed ID: 14509667
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of NMDA receptor subunits and splice variants among the CA1, CA3 and dentate gyrus of the adult rat.
    Coultrap SJ; Nixon KM; Alvestad RM; Valenzuela CF; Browning MD
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):104-11. PubMed ID: 15857673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia.
    Semwal P; Prasad S; Bhatia T; Deshpande SN; Wood J; Nimgaonkar VL; Thelma BK
    Mol Psychiatry; 2001 Mar; 6(2):220-4. PubMed ID: 11317226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter.
    Lee ES; Chen H; Shepherd KR; Lamango NS; Soliman KF; Charlton CG
    Neurosci Res; 2004 Mar; 48(3):335-44. PubMed ID: 15154679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobiology. Dopamine's reversal of fortune.
    Blakely RD
    Science; 2001 Sep; 293(5539):2407-9. PubMed ID: 11577225
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites.
    Davies HM; Hopper DW; Hansen T; Liu Q; Childers SR
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1799-802. PubMed ID: 15026075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice.
    Hanania T; Zahniser NR
    Alcohol Clin Exp Res; 2002 Apr; 26(4):431-40. PubMed ID: 11981117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.